Arbab Ali S, Frank Joseph A
Henry Ford Hospital, Cellular & Molecular Imaging Laboratory,Department of Radiology, 1 Ford Place, 2F Detroit, MI 48202, USA.
Regen Med. 2008 Mar;3(2):199-215. doi: 10.2217/17460751.3.2.199.
Hematopoietic, stromal and organ-specific stem cells are under evaluation for therapeutic efficacy in cell-based therapies of cardiac, neurological and other disorders. It is critically important to track the location of directly transplanted or infused cells that can serve as gene carrier/delivery vehicles for the treatment of disease processes and be able to noninvasively monitor the temporal and spatial homing of these cells to target tissues. Moreover, it is also necessary to determine their engraftment efficiency and functional capability following transplantation. There are various in vivo imaging modalities used to track the movement and incorporation of administered cells. Tagging stem cells with different contrast agents can make these cells probes for different imaging modalities. Recent reports have shown that stem cells labeled with iron oxides can be used as cellular MRI probes demonstrating the cell trafficking to target tissues. In this review, we will discuss the status and future prospect of stem cell tracking by cellular MRI for cell-based therapy.
造血干细胞、基质干细胞和器官特异性干细胞正在接受评估,以确定其在心脏、神经及其他疾病的细胞疗法中的治疗效果。追踪直接移植或注入的细胞的位置至关重要,这些细胞可作为基因载体/递送工具用于治疗疾病过程,并且能够以非侵入性方式监测这些细胞向靶组织的时空归巢。此外,确定它们在移植后的植入效率和功能能力也很有必要。有多种体内成像方式可用于追踪所施用细胞的运动和整合情况。用不同的造影剂标记干细胞可使这些细胞成为不同成像方式的探针。最近的报告表明,用氧化铁标记的干细胞可用作细胞MRI探针,显示细胞向靶组织的迁移。在这篇综述中,我们将讨论用于细胞治疗的细胞MRI追踪干细胞的现状和未来前景。